Four desks repriced this software name last week. It still trades below all of them.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

August 12, 2026   |   Read online   Unsubscribe   The Cloud Software Name Wall Street Just Repriced Higher One earnings report last Thursday changed how Wall Street models this software name. Four desks lifted targets the next morning, one all the way to $200, and the stock jumped 35% in a day. Even after that move you can still buy it 17% below its 52-week high and 24% below the average analyst target. Yield Focus (Sponsored) 7 High Yield Dividend Stocks to Buy Now Looking for consistent payouts? Our report features 7 top dividend stocks, including Company #3, a leader in the tobacco industry with unmatched cash flow, and Company #4, providing shareholders with reliable monthly dividends. Start boosting your income today. (By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time. - Privacy Policy) Atlassian Corporation August 11 – Pre‑market Ticker: TEAM | Sector: Technology (Software - Application) | Market Cap: ~$39.10B 30‑Second Take Why now? Four brokers repriced this name higher on August 7, and the stock still trades below every one of their targets. Bank of America upgraded to Buy with a $175 target, up from $105. Oppenheimer went to $200 from $110 on Outperform. Macquarie moved to $170 from $130, and even neutral-rated UBS lifted its target to $160 from $95. The trigger was fiscal Q4, reported August 6. Revenue came in at $1.77B against a $1.66B estimate, adjusted EPS hit $1.87 versus $1.50 expected, cloud revenue grew 31% and the company delivered its first GAAP-profitable quarter at a 12% operating margin. The stock jumped about 35% on August 7 and closed Monday at $151.87. Yes, you missed the gap. You are still buying 17% below the 52-week high of $184 and 24% below the $188 average target, with the whole sell-side moving its numbers up rather than down. The AI monetization story (Rovo, embedded AI across Jira and Confluence) is finally starting to convert into billings. That's the piece the market keeps underestimating. Trade Setup Time frame: Swing to medium-term (4 to 12 weeks) Edge type: Post-earnings analyst rerating with the price still below consensus targets Income Stocks (Sponsored) 7 “Forever” Dividend Stocks Revealed A business doesn’t boost its dividend for 50 straight years by luck. It takes consistency, resilience — and a model built to weather every market cycle. Our newest report uncovers 7 “buy and hold forever” stocks with decades of uninterrupted payouts and fortress-like financials. One healthcare giant has raised its dividend for 61 years in a row. These are the kinds of companies built to steadily grow wealth in the background. Get your free report today. (By clicking the link above, you agree to receive emails from Marketbeat. You can opt out at any time. - Privacy Policy) What's your single biggest investing regret — not a specific stock, but a pattern? Trading too much instead of holding what I already owned Being too cautious with position sizing on my best ideas Not trusting my own research over market consensus Selling quality companies just because the valuation looked full Snapshot Table Metric Value Current Stance Price $154.08 17% below the 52-week high 52‑week range $56.01 - $184.00 Average analyst target $188 Market Cap ~$39.10B Mid-large cap software Beta 1.04 Roughly in line with market P/E Ratio N/A on trailing EPS Forward P/E about 28 Avg Daily Volume 5.2M shares (3-month) 8.6M traded on the August 7 gap Next Catalyst Fiscal Q1 2027 results Expected late October 2026 Chart 1-Month Trading Summary: TEAM ground sideways in the $80 to $110 range for most of July, then gapped from $110.17 to $149.07 on August 7 after fiscal Q4 results, and added a little more Monday to close at $151.87. That is a 37% two-session move, and it still leaves the price under the fresh $160 to $200 target band and under the $184 level the stock traded at last September. A gap that size usually needs time to digest, so scale in rather than buying the whole position at once. Bull Case  Core thesis: Atlassian sells the collaboration and workflow software that keeps modern software teams running. Jira for tickets. Confluence for docs. And now Rovo for AI agents sitting on top of both. Its enterprise cloud migration story is still nowhere near done. Every customer still on data-center licenses is a future cloud upsell. That's runway you can count in years, not quarters. Catalysts: Analyst conviction is stacking up. Four desks (BofA, Oppenheimer, Macquarie, UBS) lifted targets on the same morning, with the highest at $200. That's roughly 32% above where you can buy today, and the consensus target of $188 is 24% up. When the sell-side clusters around a name like that, it usually means their models are getting more comfortable with the forward numbers. Then there's the balance of the quarter itself. Subscription ARR reached $6.6B, up 23%, and remaining performance obligations grew 44% to $4.8B. That second number is contracted revenue you can see coming. The AI product cycle is the fundamental engine. Rovo is Atlassian's AI agent layer inside Jira and Confluence, the piece that lets your teams automate ticket triage, doc summaries and workflow, and it's starting to show up in customer adoption. The market keeps underestimating how much this can lift average revenue per user across a base of hundreds of thousands of paying customers. Valuation upside: Targets on TEAM now run from $160 to $200 with a $188 average, all above where the stock trades today. Forward P/E is about 28 on a business compounding cloud revenue in the low 30s. Technical tailwind: The August 7 gap took price out of a months-long base on roughly 8.6 million shares, well above the 5.2 million daily average. Breakouts on that kind of volume tend to hold their gap. Bear Case  You need to know the downside before you buy. Software multiples have been getting compressed all year as the market questions how much of the AI narrative is real revenue versus vibes. If macro sentiment sours, or the next print shows Rovo adoption softer than the analyst upgrade cycle implies, you'll see this one punished quickly. Competition is the other thing worth watching. Microsoft's collaboration stack keeps pushing into Atlassian's turf, and Notion has been eating into the low end. Neither is existential yet. But if you see any slowdown in seat growth, it'll hit the multiple. And here's the honest risk, the one the upgrade headlines skipped. Alongside the beat, Atlassian guided full-year revenue growth to roughly 13%, down from a prior outlook near 24%. Q1 guidance came in above consensus, but the annual number is a deceleration, and you are buying after a 37% two-day move. If the next quarter shows any wobble in billings or cloud migration pace, the $200 targets get walked back as fast as they went up. Position accordingly, scale in, and keep a stop under the gap. Quick Checklist  ✅ Thesis still valid after today's close ✅ Volume confirms move above key levels ✅ Next catalyst: fiscal Q1 2027 results, expected late October 2026 Deep‑Dive Links Latest earnings report Analyst ratings and price targets Short interest data Company profile and investor relations That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned! Best Regards, —Noah Zelvis Everyday Alpha   Everyday Alpha is a publication of Elite Trade Media LLC. Disclosure: Content is for informational and entertainment purposes only and is not investment advice. Do not base investment decisions on this newsletter. Securities mentioned may be owned by our owners or operators, which could affect our objectivity. Consult a licensed financial advisor before making any investment decision. We may receive compensation from advertisers and affiliate links in this email, including for featured third-party offers. Everyday Alpha and its parent company are not registered investment advisors, broker-dealers, or financial planners. Nothing published by Everyday Alpha — including but not limited to newsletters, emails, text messages, social media posts, or website content — constitutes personalized investment advice, a recommendation to buy or sell any security, or an offer or solicitation to purchase or sell any financial instrument. All content is provided strictly for informational and educational purposes. You should not rely on any content published by Everyday Alpha as a substitute for professional financial, legal, or tax advice tailored to your individual circumstances. Always consult a qualified, licensed financial advisor before making any investment decision. Forward-Looking Statements: Content may contain forward-looking statements, including projections, opinions, and expectations regarding future events or financial performance. These statements are based on current information and assumptions at the time of writing and are inherently uncertain. Actual results may differ materially. Everyday Alpha is under no obligation to update or revise any forward-looking statement after publication. No Guarantee of Accuracy: While Everyday Alpha strives for accuracy, we make no representation or warranty — express or implied — regarding the completeness, reliability, or timeliness of any information provided. Errors, omissions, and outdated information may occur. All content is provided "as is" without warranty of any kind. Past Performance: Any reference to past performance of a security, strategy, or index is not indicative of future results. All investments carry risk, including the potential loss of principal. You could lose some or all of your invested capital. Editorial Process Disclosure: Everyday Alpha uses proprietary research tools, including AI, in its editorial process. All content is reviewed and approved by our editorial team before publication. Readers should independently verify any information before making financial decisions. Advertising & Affiliate Disclosure: Everyday Alpha receives compensation from third-party advertisers and may include paid promotions, sponsored content, and affiliate links within its publications. When you click on certain links or sign up for third-party services featured in our content, we may receive a commission or flat fee. This compensation may influence which companies or products are covered and how they are presented, though it does not affect our editorial opinions. Sponsored content is provided by advertisers and does not represent the views of Everyday Alpha. Conflicts of Interest: Contributors, editors, and affiliates of Everyday Alpha may hold positions in securities discussed in our content. These positions may be established or liquidated at any time without notice to readers. Limitation of Liability: Under no circumstances shall Everyday Alpha, its owners, employees, affiliates, or contributors be liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of or reliance on any content published by Everyday Alpha. By reading, subscribing to, or otherwise engaging with Everyday Alpha content, you acknowledge and agree to the terms above. Update your email preferences or unsubscribe here © 2026 Everyday Alpha 1032 E Brandon Blvd #9644 Brandon, FL 33511, United States